Challenge of BALB/c Mice with Respiratory Syncytial Virus Does Not Enhance the Th2 Pathway Induced after Immunization with a Recombinant G Fusion Protein, BBG2NA, in Aluminum Hydroxide-Reference-Cited by-同舟云学术

Challenge of BALB/c Mice with Respiratory Syncytial Virus Does Not Enhance the Th2 Pathway Induced after Immunization with a Recombinant G Fusion Protein, BBG2NA, in Aluminum Hydroxide

Published:1997-09 Issue:3 Volume:176 Page:560-569
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Corvaïa Nathalie,Tournier Patricia,Nguyen Thien Ngoc,Haeuw Jean François,Power Ultan F.,Binz Hans,Andréoni Christine

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/176/3/560/2588234/176-3-560.pdf

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection;Expert Opinion on Drug Discovery;2022-09-20

2. Up-to-date role of biologics in the management of respiratory syncytial virus;Expert Opinion on Biological Therapy;2020-04-17

3. DNA vaccine encoding central conserved region of G protein induces Th1 predominant immune response and protection from RSV infection in mice;Immunology Letters;2016-11

4. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease;Virology;2016-07

5. Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels;Journal of Virology;2015-05-27